⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31313385 | 0.86 | SIK1 (0.33) | — | |
| SCHEMBL31313391 | 0.86 | SIK1 (0.35) | — | |
| SCHEMBL31313181 | 0.85 | SIK1 (0.33) | — | |
| SCHEMBL31313227 | 0.84 | SIK1 (0.33) | — | |
| SCHEMBL31313159 | 0.83 | SIK1 (0.37) | — | |
| SCHEMBL31312971 | 0.82 | SIK1 (0.31) | — | |
| SCHEMBL31313208 | 0.79 | SIK1 (0.42) | — | |
| SCHEMBL31313262 | 0.79 | — | — | |
| SCHEMBL31313341 | 0.77 | SYK (0.41) | — | |
| SCHEMBL31313132 | 0.75 | EIF4EBP1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4737443-A1 | SALT-INDUCIBLE KINASE INHIBITORY COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | Tanabe Pharma Corporation (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-20260062387-A1 | SALT-INDUCIBLE KINASE INHIBITOR COMPOUND AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2026-03-05 | — | — | US | disclosed |
| WO-2024242169-A1 | SALT-INDUCIBLE KINASE INHIBITORY COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | 田辺三菱製薬株式会社 | 2024-11-28 | — | — | WO | disclosed |